Nesoya, Norway

Lucas Altepost

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucas Altepost. Retrieved from https://idiyas.com/inventor/lucas-altepost

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucas Altepost and Patent Innovation in Pulmonary Fibrosis Treatment.

Introduction

Lucas Altepost is an inventor associated with Nesøya, Norway, and Axichem AB. His patent work concerns potential approaches to treating idiopathic pulmonary fibrosis, a serious lung disease.

Latest Patents

Altepost is associated with 1 patent: “Capsaicin Derivatives in the Treatment of Idiopathic Pulmonary Fibrosis.” The invention describes compounds and compositions for use in treating idiopathic pulmonary fibrosis. It also addresses methods for inhibiting the activity of platelet-derived growth factor receptors PDGF-α and/or PDGF-β in a subject in need of treatment.

Career Highlights

The available information connects Altepost’s inventive work with Axichem AB and research into therapeutic applications of capsaicin derivatives. His patent focuses on a specific disease-treatment area and related biological targets.

Collaborations

Altepost’s listed coworkers include Erik Lager and Torsten Helsing. Their names provide context for the professional network associated with his work.

Conclusion

Lucas Altepost’s patent activity centers on a proposed therapeutic approach to idiopathic pulmonary fibrosis, including compounds and methods involving PDGF receptor inhibition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…